Amanote Research
Register
Sign In
Investigating the Role of Nuclear Receptor Proliferator-Activated Receptor Delta (PPARδ) in Aging and Metabolic Models of Osteoarthritis
Osteoarthritis and Cartilage
- United Kingdom
doi 10.1016/j.joca.2019.02.137
Full Text
Open PDF
Abstract
Available in
full text
Categories
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
Date
April 1, 2019
Authors
B.C. To
A. Ratneswaran
G. Kerr
F. Beier
Publisher
Elsevier BV
Related search
Peroxisome Proliferator–activated Receptor-Δ (PPARD; PPARB; PPARδ)
Science-Business eXchange
Human Metabolic Syndrome Resulting From Dominant-Negative Mutations in the Nuclear Receptor Peroxisome Proliferator-Activated Receptor-
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
The Peroxisome Proliferator-Activated Receptor , an Integrator of Transcriptional Repression and Nuclear Receptor Signaling
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Expression of Peroxisome Proliferator-Activated Receptor PPARδ Promotes Induction of PPARγ and Adipocyte Differentiation in 3T3C2 Fibroblasts
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Nuclear Receptor Corepressor-Dependent Repression of Peroxisome-Proliferator-Activated Receptor Δ-Mediated Transactivation
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Peroxisome Proliferator-Activated Receptor
Peroxisome Proliferator Activated Receptor
Role of Peroxisome Proliferator-Activated Receptor (PPARγ) in Metabolic Disorders in SGA With Catch-Up Growth
Obesity
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
Peroxisome Proliferator-Activated Receptor Modulation During Metabolic Diseases and Cancers: Master and Minions
PPAR Research
Drug Discovery
Pharmacology